These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32201138)

  • 21. A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants.
    Ok Baik Y; Lee Y; Lee C; Kyung Kim S; Park J; Sun M; Jung D; Young Jang J; Jun Yong T; Woo Park J; Jeong S; Lim S; Hyun Han S; Keun Choi S
    Vaccine; 2023 Mar; 41(10):1753-1759. PubMed ID: 36774331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.
    Shakya M; Voysey M; Theiss-Nyland K; Colin-Jones R; Pant D; Adhikari A; Tonks S; Mujadidi YF; O'Reilly P; Mazur O; Kelly S; Liu X; Maharjan A; Dahal A; Haque N; Pradhan A; Shrestha S; Joshi M; Smith N; Hill J; Clarke J; Stockdale L; Jones E; Lubinda T; Bajracharya B; Dongol S; Karkey A; Baker S; Dougan G; Pitzer VE; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ;
    Lancet Glob Health; 2021 Nov; 9(11):e1561-e1568. PubMed ID: 34678198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study.
    Phillips MT; Antillon M; Bilcke J; Bar-Zeev N; Limani F; Debellut F; Pecenka C; Neuzil KM; Gordon MA; Thindwa D; Paltiel AD; Yaesoubi R; Pitzer VE
    BMC Infect Dis; 2023 Mar; 23(1):143. PubMed ID: 36890448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas.
    Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.
    Shaum A; Mujuru HA; Takamiya M; Ticklay I; Nathoo K; Sreenivasan N; Nyambayo P; Chitando P; Marembo J; Koline Chigodo C; Mukaratirwa A; Jacha V; Gidudu JF; Rupfutse M; Kumar Jain S; Manangazira P; Bennett SD
    Vaccine; 2022 Jun; 40(26):3573-3580. PubMed ID: 35568590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial.
    Sirima SB; Ouedraogo A; Barry N; Siribie M; Tiono A; Nébié I; Konaté A; Berges GD; Diarra A; Ouedraogo M; Bougouma EC; Soulama I; Hema A; Datta S; Liang Y; Rotrosen ET; Tracy JK; Jamka LP; Oshinsky JJ; Pasetti MF; Neuzil KM; Laurens MB
    Int J Infect Dis; 2021 Jul; 108():465-472. PubMed ID: 34082090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longevity of immune response following a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan.
    Qamar FN; Qureshi S; Haq Z; Yousafzai T; Qazi I; Irfan S; Iqbal N; Amalik Z; Hotwani A; Ali Q; Fatima I; Rahman N; Carter AS; Seidman JC
    Int J Infect Dis; 2024 Jul; ():107187. PubMed ID: 39038733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label, comparative, single dose, clinical Phase Ⅰ study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults.
    Choi SK; Baik YO; Kim CW; Kim SK; Oh IN; Yoon H; Yu D; Lee C
    Vaccine; 2021 May; 39(19):2620-2627. PubMed ID: 33849723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
    Lightowler MS; Manangazira P; Nackers F; Van Herp M; Phiri I; Kuwenyi K; Panunzi I; Garone D; Marume F; Tarupiwa A; Ferreras E; Duri C; Luquero FJ
    Vaccine; 2022 Jul; 40(31):4199-4210. PubMed ID: 35690501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of a comprehensive typhoid conjugate vaccine campaign on antimicrobial prescribing in children in Harare, Zimbabwe: a mixed methods study.
    Olaru ID; Chingono RMS; Bottomley C; Kandiye FR; Mhino F; Nyamayaro CA; Manyau S; Vere M; Chitando P; Chonzi P; Darton TC; Dixon J; Kranzer K
    Lancet Glob Health; 2023 Sep; 11(9):e1422-e1431. PubMed ID: 37591588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study.
    Qamar FN; Yousafzai MT; Khalid M; Kazi AM; Lohana H; Karim S; Khan A; Hotwani A; Qureshi S; Kabir F; Aziz F; Memon NM; Domki MH; Hasan R
    Lancet Infect Dis; 2018 Dec; 18(12):1368-1376. PubMed ID: 30507460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM
    Thuluva S; Paradkar V; Matur R; Turaga K; Gv SR
    Hum Vaccin Immunother; 2022 Nov; 18(5):2043103. PubMed ID: 35333702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction of typhoid vaccine in the expanded immunization program of Pakistan.
    Aslam F; Yue Y; Aziz M
    Hum Vaccin Immunother; 2021 Jul; 17(7):2132. PubMed ID: 33522429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
    Hoffman SA; LeBoa C; Date K; Haldar P; Harvey P; Shimpi R; An Q; Zhang C; Jayaprasad N; Horng L; Fagerli K; Borhade P; Daruwalla S; Dharmapalan D; Gavhane J; Joshi S; Rai R; Rathod V; Shetty K; Warrier DS; Yadav S; Chakraborty D; Bahl S; Katkar A; Kunwar A; Yewale V; Andrews JR; Bhatnagar P; Dutta S; Luby SP
    Clin Infect Dis; 2023 Jul; 77(1):138-144. PubMed ID: 36947143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Typhoid conjugate vaccine perceptions and coverage among children and adults: Findings from a post-campaign coverage survey - Harare, Zimbabwe, 2019.
    Gharpure R; Longley AT; Takamiya M; Hidle A; Munyanyi M; Chawurura T; Maxwell L; Mamire G; Chaora G; Chakauya J; Rupfutse M; Poncin M; Gasasira A; Date K; Manangazira P; Sreenivasan N
    Vaccine; 2024 Jul; ():. PubMed ID: 38991917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
    Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
    De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
    Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    Hills SL; Soeung SC; Sarath S; Morn C; Dara C; Fischer M; Thigpen MC
    PLoS One; 2022; 17(6):e0269480. PubMed ID: 35679297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.